Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.
Here’s what you may have missed over the last week:
One in Three Americans Use Cannabis to Cope with Holiday Family Stress
A new poll released this week by the Freeman Recovery Center found that nearly one in three Americans turn to marijuana before family holiday gatherings to manage stress and prepare emotionally. Respondents cited the need to relax amid tense dynamics as a key reason.
This trend highlights growing cultural acceptance of cannabis as a tool for mental wellness during high-pressure social events, with users reporting it helps them stay calm and engaged.
Khalifa Kush Holds Top Spot in Celebrity Cannabis Brands
Wiz Khalifa’s Khalifa Kush brand secured the number one position in celebrity cannabis sales for the second year running, based on data published December 15. Strong consumer demand kept it ahead in a competitive field.
Brands like Cheech & Chong Cannabis and Dr. Greenthumb’s climbed the rankings, while others such as Tyson 2.0 and Willie’s Reserve slipped.
Kentucky Opens First Medical Cannabis Dispensary
Kentucky reached a program milestone when its first medical marijuana dispensary opened this week. Governor Andy Beshear confirmed sales are underway, with products now available nearly a year after legalization.
Patients lined up for access, many seeking relief from conditions like chronic pain as an alternative to opioids. The launch expands options in a region slow to adopt cannabis reform.
PharmaCann Sells Colorado Retail Assets for $49 Million
Multi-state operator PharmaCann completed a deal December 17 to sell select Colorado retail stores to Vireo Growth Inc. for $49 million in shares. The move trims its portfolio in a mature market.
This sale points to ongoing consolidation as companies focus on profitable operations amid falling prices and fewer cultivation licenses nationwide.
Cannabis Stocks Decline After Policy Announcement
Major U.S. cannabis stocks dropped this week following the executive order on federal changes. Shares in operators like Trulieve fell over 20%, Green Thumb Industries down more than 15%, and the AdvisorShares Pure US Cannabis ETF slid nearly 30%.
Investors weighed potential long-term gains from tax relief against risks of increased competition from larger firms entering the space.
